NANJING WELL PHARMACEUTICAL GROUP CO.,LTD.

Nanjing Well Pharmaceutical Group Co.,Ltd.

603351

CNE100003JD4

Oil & Gas Refining and Marketing

End-of-day quote Shanghai S.E. Other stock markets 18:00:00 2024-05-30 EDT			5-day change	1st Jan Change
23.3 ^CNY	+0.82%		-2.96%	-11.64%

04-25	Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
2023	Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	CI

Nanjing Market Supervision and Administration Bureau has Changed its Name to Nanjing Well Pharmaceutical Co.,Ltd

April 22, 2020

Nanjing Market Supervision and Administration Bureau changed its name to Nanjing Well Pharmaceutical Co.,Ltd.

Latest news about Nanjing Well Pharmaceutical Group Co.,Ltd.

Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-25	CI
Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-28	CI
Nanjing Well Pharmaceutical Group Co.,Ltd. completed the acquisition of13% stake in Nanjing Xingwei Biotechnology Co., Ltd. from Wu Renrong, Gao Zhengsong, Chen Xinguo, Tang Qunsong, Shen Jiusi, Wu Rongwen, Hong Shilin, Zou Jianguo, Wang Fuqiu and Zhou Chong.	23-08-16	CI
Nanjing Well Pharmaceutical Group Co.,Ltd. signed an agreement to acquire 13% stake in Nanjing Xingwei Biotechnology Co., Ltd. from Wu Renrong, Gao Zhengsong, Chen Xinguo, Tang Qunsong, Shen Jiusi, Wu Rongwen, Hong Shilin, Zou Jianguo, Wang Fuqiu and Zhou Chong for CNY0.	23-08-16	CI
Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-24	CI
Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-24	CI
Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-22	CI
Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-26	CI
Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-18	CI
Certain A Shares of Nanjing Well Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 30-JAN-2022.	22-01-29	CI
Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-28	CI
Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-07-29	CI
Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-26	CI
Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-12	CI
Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	20-10-23	CI
Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020	20-08-19	CI
Nanjing Well Pharmaceutical Group Co.,Ltd.(XSSC:603351) dropped from S&P Global BMI Index	20-06-22	CI
Nanjing Well Pharmaceutical Co., Ltd. Announces Cash Dividend for the Year 2019, Payable on May 27, 2020	20-05-19	CI
Nanjing Well Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-04-27	CI
Nanjing Market Supervision and Administration Bureau has Changed its Name to Nanjing Well Pharmaceutical Co.,Ltd	20-04-22	CI
Nanjing Well Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019	20-04-20	CI
Certain A Shares of Nanjing Well Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 30-JAN-2020.	20-01-29	CI
Nanjing Well Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2019	19-10-28	CI

Chart Nanjing Well Pharmaceutical Group Co.,Ltd.

Duration

Period

Chart Nanjing Well Pharmaceutical Group Co.,Ltd.

More charts

Nanjing Well Pharmaceutical Group Co Ltd, formerly Nanjing Well Pharmaceutical Co Ltd, is a China-based company principally involved in the research and development, manufacturing and sales of pharmaceutical auxiliary materials and synthetic lubricating base oil products. Its main products include pharmaceutical auxiliary materials, synthetic lubricating base oil and pesticide additives. The Company distributes its products primarily in domestic market.

Sector

Oil & Gas Refining and Marketing

Calendar

2024-08-19 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Oil & Gas Refining and Marketing

	1st Jan change	Capi.
NANJING WELL PHARMACEUTICAL GROUP CO.,LTD.	-11.64%	436M
RELIANCE INDUSTRIES LTD	+10.67%	232B
CHINA PETROLEUM & CHEMICAL CORPORATION	+21.27%	102B
BP PLC	+4.72%	102B
MARATHON PETROLEUM CORPORATION	+19.04%	62.23B
PHILLIPS 66	+6.74%	60.25B
VALERO ENERGY CORPORATION	+20.88%	51.38B
IMPERIAL OIL LIMITED	+27.58%	37.82B
INDIAN OIL CORPORATION LIMITED	+25.07%	26.8B
REPSOL S.A.	+11.67%	19.82B